Long-term survival of patients with invasive ultra-thin cutaneous melanoma

A single-center retrospective analysis

Antonella Vecchiato, Elisa Zonta, Luca Campana, Giacomo Dal Bello, Marco Rastrelli, Carlo Riccardo Rossi, Mauro Alaibac

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The incidence of cutaneous melanoma is increasing worldwide, especially for thin melanoma (Breslow ≤ 1 mm). Thin cutaneous melanoma has a favorable prognosis but there are few data about the prognosis of patients with ultra-thin cutaneous melanoma (Breslow ≤ 0.5 mm). Our aim was to investigate the disease-free survival among patients with invasive cutaneous melanoma with Breslow ≤ 0.5 mm after 10 years from the initial diagnosis. A retrospective review of 240 cutaneous melanoma patients with Breslow ≤ 0.5 mm was performed. Recurrence, death from cutaneous melanoma, and disease-free survival were all identified. In the whole group of patients, we observed only 2 deaths from cutaneous melanoma. Median follow-up was 13, 11 years. Among all 240 patients, 221 were alive and disease free, 2 died of cutaneous melanoma, 11 died of other non-neoplastic diseases, 5 died of other neoplastic diseases different from melanoma, and 1 patient had a local recurrence; therefore the 10-year melanoma survival rate was 99.6%. Our data indicate that death from cutaneous melanoma in the group of patients with Breslow

Original languageEnglish
Article numbere2452
JournalMedicine (United States)
Volume95
Issue number2
DOIs
Publication statusPublished - 2016

Fingerprint

Melanoma
Skin
Survival
Disease-Free Survival
Recurrence
Skin Diseases
Survival Rate
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{1ee264467f1748b3aefeb45a60a8d934,
title = "Long-term survival of patients with invasive ultra-thin cutaneous melanoma: A single-center retrospective analysis",
abstract = "The incidence of cutaneous melanoma is increasing worldwide, especially for thin melanoma (Breslow ≤ 1 mm). Thin cutaneous melanoma has a favorable prognosis but there are few data about the prognosis of patients with ultra-thin cutaneous melanoma (Breslow ≤ 0.5 mm). Our aim was to investigate the disease-free survival among patients with invasive cutaneous melanoma with Breslow ≤ 0.5 mm after 10 years from the initial diagnosis. A retrospective review of 240 cutaneous melanoma patients with Breslow ≤ 0.5 mm was performed. Recurrence, death from cutaneous melanoma, and disease-free survival were all identified. In the whole group of patients, we observed only 2 deaths from cutaneous melanoma. Median follow-up was 13, 11 years. Among all 240 patients, 221 were alive and disease free, 2 died of cutaneous melanoma, 11 died of other non-neoplastic diseases, 5 died of other neoplastic diseases different from melanoma, and 1 patient had a local recurrence; therefore the 10-year melanoma survival rate was 99.6{\%}. Our data indicate that death from cutaneous melanoma in the group of patients with Breslow",
author = "Antonella Vecchiato and Elisa Zonta and Luca Campana and {Dal Bello}, Giacomo and Marco Rastrelli and Rossi, {Carlo Riccardo} and Mauro Alaibac",
year = "2016",
doi = "10.1097/MD.0000000000002452",
language = "English",
volume = "95",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Long-term survival of patients with invasive ultra-thin cutaneous melanoma

T2 - A single-center retrospective analysis

AU - Vecchiato, Antonella

AU - Zonta, Elisa

AU - Campana, Luca

AU - Dal Bello, Giacomo

AU - Rastrelli, Marco

AU - Rossi, Carlo Riccardo

AU - Alaibac, Mauro

PY - 2016

Y1 - 2016

N2 - The incidence of cutaneous melanoma is increasing worldwide, especially for thin melanoma (Breslow ≤ 1 mm). Thin cutaneous melanoma has a favorable prognosis but there are few data about the prognosis of patients with ultra-thin cutaneous melanoma (Breslow ≤ 0.5 mm). Our aim was to investigate the disease-free survival among patients with invasive cutaneous melanoma with Breslow ≤ 0.5 mm after 10 years from the initial diagnosis. A retrospective review of 240 cutaneous melanoma patients with Breslow ≤ 0.5 mm was performed. Recurrence, death from cutaneous melanoma, and disease-free survival were all identified. In the whole group of patients, we observed only 2 deaths from cutaneous melanoma. Median follow-up was 13, 11 years. Among all 240 patients, 221 were alive and disease free, 2 died of cutaneous melanoma, 11 died of other non-neoplastic diseases, 5 died of other neoplastic diseases different from melanoma, and 1 patient had a local recurrence; therefore the 10-year melanoma survival rate was 99.6%. Our data indicate that death from cutaneous melanoma in the group of patients with Breslow

AB - The incidence of cutaneous melanoma is increasing worldwide, especially for thin melanoma (Breslow ≤ 1 mm). Thin cutaneous melanoma has a favorable prognosis but there are few data about the prognosis of patients with ultra-thin cutaneous melanoma (Breslow ≤ 0.5 mm). Our aim was to investigate the disease-free survival among patients with invasive cutaneous melanoma with Breslow ≤ 0.5 mm after 10 years from the initial diagnosis. A retrospective review of 240 cutaneous melanoma patients with Breslow ≤ 0.5 mm was performed. Recurrence, death from cutaneous melanoma, and disease-free survival were all identified. In the whole group of patients, we observed only 2 deaths from cutaneous melanoma. Median follow-up was 13, 11 years. Among all 240 patients, 221 were alive and disease free, 2 died of cutaneous melanoma, 11 died of other non-neoplastic diseases, 5 died of other neoplastic diseases different from melanoma, and 1 patient had a local recurrence; therefore the 10-year melanoma survival rate was 99.6%. Our data indicate that death from cutaneous melanoma in the group of patients with Breslow

UR - http://www.scopus.com/inward/record.url?scp=84958212180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958212180&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000002452

DO - 10.1097/MD.0000000000002452

M3 - Article

VL - 95

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 2

M1 - e2452

ER -